Position in BUDZ
as of Mar 31, 2023
· filed Dec 12, 2023
Position Value
$4,446
New position
Shares Held
74,111
first reported quarter
Ownership
0.050%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#1
of 2 holders
Holding Since
Mar 2023
1 quarter on record
Voting authority
Sole 100%
Shared 0%
None 0%
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026Fisher Asset Management, LLC holds $131,969,402 across 8 Drug Manufacturers - Specialty & Generic names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | BCRX |
Biocryst Pharmaceuticals Inc
|
2,604,027 | $26,040,270 | |
| 2 | KNSA |
Kiniksa Pharmaceuticals International, plc
|
398,266 | $25,469,110 | |
| 3 | NBIX |
Neurocrine Biosciences Inc
|
135,104 | $22,770,428 | |
| 4 | ALKS |
Alkermes plc.
|
419,102 | $21,960,944 | |
| 5 | UTHR |
UNITED THERAPEUTICS Corp
|
33,836 | $18,333,359 | |
| 6 | PBH |
Prestige Consumer Healthcare Inc.
|
247,474 | $11,698,095 | |
| 7 | HLN |
Haleon plc
|
329,891 | $3,077,883 | |
| 8 | RDY |
Dr Reddys Laboratories Ltd
|
180,767 | $2,619,313 |
All Filings in BUDZ
Export CSV
1 filing row on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2023-03-31 | $4,446 | 74,111 | Shares | Sole | 2023-12-12 | |
| No filing history on record for this holder in this stock. | ||||||